INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

20,315 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$810K
13.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

Page 136 of 508
← PrevNext →
27
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL
$683K
10.9K sh
Sep 1, 2026
Sep 3, 2026
traded Sep 1, 2026
+2d
SEC Form 4

Evidence

26
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
9,812 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

26
CE
Creviston Steven ESVP, Connectivity & Sensors
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$297K
2,958 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

25
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$1.22M
12.0K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

25
BA
Bruggeworth Robert ADirector, President and CEO
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$1.68M
16.7K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

25
Lantheus Holdings, Inc.10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$112K
35.8K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

24
WM
Willrath MatthewVP & CAO
GPORGULFPORT ENERGY CORP
Open-market sale
SELL$59K
325 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

23
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$1.49M
52.9K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

23
CE
Creviston Steven ESVP, Connectivity & Sensors
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$188K
1,852 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

22
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$4.88M
15.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

20
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
1,000 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

20
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$80K
22.2K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

20
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
18.4K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

20
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$320K
11.5K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

19
FJ
Fego Paul JSVP, Global Operations
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$240K
2,400 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

19
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
5,439 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

19
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.42M
13.3K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

19
LC
Llewellyn Lindsay CatherineSEE REMARKS
LYFTLyft, Inc.
Open-market sale · 10b5-1 plan
SELL$220K
13.2K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

18
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$222K
34.1K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

17
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$113K
4,075 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$4.96M
15.2K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

16
FJ
Fego Paul JSVP, Global Operations
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
100 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

15
GK
Guarini KathrynDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$340K
400 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$54.02
2 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$275K
6,348 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$8,177
3,618 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$4,793
2,121 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$13K
5,863 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$821K
19.3K sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

14
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$746K
17.4K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$5,973
2,643 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

13
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$36K
15.0K sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

13
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
6,862 sh
Aug 28, 2026Sep 3, 2026
traded Aug 28, 2026
+6dSEC Form 4

Evidence

12
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$767K
7,215 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

11
BC
Barrett CherieSVP, Chief Accounting Officer
DOCNDigitalOcean Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$421K
3,985 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

10
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$89K
1,090 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

10
HJ
Hawkins Matthew J.Director, Chief Executive Officer
WAYWaystar Holding Corp.
Open-market sale · 10b5-1 plan
SELL$2.14M
82.5K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

10
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$109K
1,344 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

9
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$320K
1,000 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence